Topics:
Gynecologic Cancers • Medical Oncology • NCI-CCC Tumor Board Question • University of Florida • NCI-CCC Gynecologic Tumor Board Question
How would you adjust therapy for a patient with high risk, stage III choriocarcinoma (lung mets) in the context of renal insufficiency (Cr 3.8)?
Answer from: at Community Practice
Risk score might dictate chemo regimen. There are dose adjustments for Methotrexate & Cytoxan based on renal function for MAC which you could use if risk score 7 or 8. I’d follow MTX levels & dose folinic acid until nontoxic MTX levels. If higher score I’d use EMA +/- CO. Co...
Sign in or Register to read more